SCHEMBL3396178

SCHEMBL3396178

CC(C)(C=O)Cc1c[nH]c2ncc(-c3cccc(NCCS(C)(=O)=O)c3)nc12

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
BTK Q06187 2/20 0.41
ITK Q08881 2/20 0.41
JAK3 P52333 4/20 0.39
TYRO3 Q06418 5/20 0.38
NPC1 O15118 1/20 0.37
JAK2 O60674 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK1 P28482 1/20 0.35
SYK P43405 3/20 0.34
ATR Q13535 2/20 0.34
TDO2 P48775 1/20 0.34
BRAF P15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3394454 0.86 JAK3 (0.41) BTKITKJAK3TYRO3NPC1
SCHEMBL3396088 0.84 JAK3 (0.42) BTKITKJAK3NPC1RAB9A
SCHEMBL3399105 0.83 JAK3 (0.39) BTKITKJAK3NPC1JAK2
SCHEMBL3397744 0.83 NPC1 (0.41) BTKITKJAK3TYRO3NPC1
SCHEMBL3394488 0.81 JAK3 (0.40) BTKITKJAK3NPC1RAB9A
SCHEMBL2277329 0.80 JAK3 (0.55) BTKITKJAK3TYRO3SYK
SCHEMBL3398248 0.80 MAPK1 (0.40) BTKITKJAK3NPC1RAB9A
SCHEMBL3396277 0.79 JAK3 (0.39) BTKITKJAK3NPC1RAB9A
SCHEMBL3393665 0.77 TTK (0.38) BTKITKJAK3JAK2MAPK1
SCHEMBL3398992 0.76 JAK3 (0.42) BTKITKJAK3MAPK1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP claimed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO claimed
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO disclosed